Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study

Alzheimer’s disease (AD) is a progressive neurodegeneration characterized by neuron death ending in memory and cognitive decline. A major concern in AD research is the identification of new therapeutics that could prevent or delay the onset of the disorder, with current treatments being effective on...

Descripción completa

Detalles Bibliográficos
Autores principales: Cecarini, Valentina, Bonfili, Laura, Gogoi, Olee, Lawrence, Solomon, Venanzi, Franco M., Azevedo, Vasco, Mancha-Agresti, Pamela, Drumond, Mariana Martins, Rossi, Giacomo, Berardi, Sara, Galosi, Livio, Cuccioloni, Massimiliano, Angeletti, Mauro, Suchodolski, Jan S., Pilla, Rachel, Lidbury, Jonathan A., Eleuteri, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485699/
https://www.ncbi.nlm.nih.gov/pubmed/32855357
http://dx.doi.org/10.18632/aging.103900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485699/
https://www.ncbi.nlm.nih.gov/pubmed/32855357
http://dx.doi.org/10.18632/aging.103900

Ejemplares similares